Check out market updates

Brickell Biotech prepares $50M at-the-market offering to fund company through Phase III trials

BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) is preparing to sell up to $50 million in new stock sales to […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *